Larimar Therapeutics (LRMR) PT Raised to $43 at JMP Securities, Following Clinical Business Update
Tweet Send to a Friend
JMP Securities analyst Jonathan Wolleben ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
